BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29980054)

  • 1. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".
    Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E
    Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).
    Bashir B; Kwok S; Wierzbicki AS; Jones A; Dawson C; Downie P; Jenkinson F; Delaney H; Mansfield M; Datta D; Teoh Y; Hamilton P; Forrester N; O'Sullivan D; Ferdousi M; Durrington PN; AbdelRazik A; Gallo A; Moulin P; Soran H
    Atherosclerosis; 2024 Apr; 391():117476. PubMed ID: 38447437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency.
    Xia Y; Zheng W; Du T; Gong Z; Liang L; Wang R; Yang Y; Zhang K; Lu D; Chen X; Sun Y; Sun Y; Xiao B; Qiu W
    J Clin Lipidol; 2023; 17(6):808-817. PubMed ID: 37858495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology and emerging treatments for familial chylomicronemia syndrome.
    Spagnuolo CM; Hegele RA
    Expert Rev Endocrinol Metab; 2024 Jul; 19(4):299-306. PubMed ID: 38866702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS).
    Jones A; Peers K; Wierzbicki AS; Ramachandran R; Mansfield M; Dawson C; Ochoa-Ferraro A; Soran H; Jenkinson F; McDowell I; Downie P; Hamilton P; Jones RD
    Atherosclerosis; 2023 Jun; 375():67-74. PubMed ID: 37253281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hypertriglyceridemia: Existing and emerging therapies.
    Malick WA; Do R; Rosenson RS
    Pharmacol Ther; 2023 Nov; 251():108544. PubMed ID: 37848164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frameshift coding sequence variants in the LPL gene: identification of two novel events and exploration of the genotype-phenotype relationship for variants reported to date.
    Zhang G; Hu Y; Yang Q; Pu N; Li G; Zhang J; Tong Z; Masson E; Cooper DN; Chen JM; Li W
    Lipids Health Dis; 2023 Aug; 22(1):128. PubMed ID: 37568214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
    Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
    BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatitis risk in genetic subtypes of multifactorial chylomicronemia syndrome.
    Berberich AJ; Hegele RA
    Atherosclerosis; 2024 May; 392():117528. PubMed ID: 38594114
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia.
    Guay SP; Paquette M; Taschereau A; Girard L; Desgagné V; Bouchard L; Bernard S; Baass A
    Atherosclerosis; 2024 May; 392():117489. PubMed ID: 38448342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia.
    Maltais M; Brisson D; Gaudet D
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33572376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial chylomicronemia syndrome: The first case reported in Ecuador.
    Garay García KJ; Chong Menendez RJ; Nogueira JP; Piedra Andrade JS
    Clin Investig Arterioscler; 2022; 34(6):326-329. PubMed ID: 36184299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking the chains of lipoprotein lipase deficiency: A pediatric perspective on the efficacy and safety of Volanesorsen.
    den Hollander B; Brands MM; Nijhuis IJM; Doude van Troostwijk LJAE; van Essen P; Hofsteenge GH; Koot BG; Müller AR; Tseng LA; Stroes ESG; van de Ven PM; Wiegman A; van Karnebeek CDM
    Mol Genet Metab; 2024 May; 142(1):108347. PubMed ID: 38401382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial.
    Witztum JL; Gaudet D; Arca M; Jones A; Soran H; Gouni-Berthold I; Stroes ESG; Alexander VJ; Jones R; Watts L; Xia S; Tsimikas S
    J Clin Lipidol; 2023; 17(3):342-355. PubMed ID: 37100699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency.
    Yoldas Celik M; Canda E; Yazici H; Erdem F; Yuksel Yanbolu A; Atik Altinok Y; Pariltay E; Akin H; Kalkan Ucar S; Coker M
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1798-1806. PubMed ID: 38503616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28.
    Kaiser K; Fox RS; Perschon C; Vera-Llonch M; Alonso J; Cubells L; Cella D
    Qual Life Res; 2023 Feb; 32(2):605-614. PubMed ID: 36310187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of neonatal-onset type I hyperlipoproteinemia with bloody ascites].
    Chen YY; Hu LY; Zhang K; Zhang XP; Cao Y; Yang L; Wu BB; Zhou WH; Wang J
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Dec; 25(12):1293-1298. PubMed ID: 38112150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome.
    Guay SP; Paquette M; Taschereau A; Desgagné V; Bouchard L; Bernard S; Baass A
    J Clin Lipidol; 2024; 18(3):e413-e422. PubMed ID: 38443284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia.
    Bashir B; Ferdousi M; Durrington P; Soran H
    Curr Opin Lipidol; 2024 Aug; 35(4):208-218. PubMed ID: 38841827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characterization and mutation spectrum of patients with hypertriglyceridemia in a German outpatient clinic.
    Bardey F; Rieck L; Spira D; März W; Binner P; Schwab S; Kleber ME; Danyel M; Barkowski R; Bobbert T; Spranger J; Steinhagen-Thiessen E; Demuth I; Kassner U
    J Lipid Res; 2024 Jul; ():100589. PubMed ID: 38969064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.